Cargando…
Barriers to the Wider Use of Pre-exposure Prophylaxis in the United States: A Narrative Review
Antiretroviral pre-exposure prophylaxis (PrEP) to prevent HIV transmission was first approved by the US Food and Drug Administration in 2012. Despite correlations of decreases in new HIV infections being greatest where PrEP has been deployed, the uptake of PrEP is lagging, particularly among populat...
Autores principales: | Mayer, Kenneth H., Agwu, Allison, Malebranche, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467490/ https://www.ncbi.nlm.nih.gov/pubmed/32232664 http://dx.doi.org/10.1007/s12325-020-01295-0 |
Ejemplares similares
-
Antiretroviral pre-exposure prophylaxis implementation in the United States: a work in progress
por: Mayer, Kenneth H, et al.
Publicado: (2015) -
Estimated Impact of Targeted Pre-Exposure Prophylaxis: Strategies for Men Who Have Sex with Men in the United States
por: Elion, Richard A., et al.
Publicado: (2019) -
State same‐sex marriage policies and pre‐exposure prophylaxis implementation among men who have sex with men in the United States
por: Raifman, Julia, et al.
Publicado: (2023) -
Top Questions in ID: Pre-exposure Prophylaxis for HIV
por: Krakower, Douglas S, et al.
Publicado: (2017) -
Pre-Exposure Prophylaxis Training among Medical Schools in the United States
por: Cooper, Robert L., et al.
Publicado: (2021)